CHOP Expert Commentary – Impact of COVID-19 on African American Community
Learn how Kim Smith-Whitley, MD, is fighting to improve the lives of her patients in the wake of COVID-19.
Read moreDivision of Hematology News and Updates
1 - 10 of 35
Novel Sepsis Treatment Enhances Bacterial Capture by Neutrophil “Traps”
Published on in CHOP News
New treatment developed by CHOP researchers poised to improve sepsis outcomes.
Breakthrough New Therapies Approved for the Treatment of Sickle Cell Disease
The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
Read moreCHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Published on in CHOP in the Media
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
New Studies Provide Important New Clues For Treating Red Blood Cell Disorders
Published on in CHOP News
Stefano Rivella, PhD, an expert in creating the next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia, has led three new published studies that make significant contributions to the scientific body of literature regarding red blood cells, and how manipulating the production of red cells can lead to the development of new disease-modifying therapies.
Joe Oved, MD, Joins the Comprehensive Bone Marrow Failure Center at CHOP
Published on in CHOP News
Dr. Oved brings deep expertise to the group, having completed scientific and clinical training that included tenures as a Fulbright Fellow with the Weizmann Institute in Israel, the NYU School of Medicine with two years as a Howard Hughes Medical Fellow, followed by a residency in Pediatrics at NYP Weill Cornell Medical College.
CHOP Hematologist Dr. Lindsey George Receives 2019 Clinical Achievement Research Award
Published on in CHOP News
Dr. George was recognized for the first gene therapy clinical trial to report a cure of hemophilia B patients.
Sideroblastic Anemia Is a Red-flag Sign of Single Large-scale Mitochondrial DNA Deletion Syndrome
Published on in Children's Doctor
Using the case of a 24-month-old African-American boy, Drs. Ganetzky and Goldstein discuss sideroblastic anemia and how it might be an indicator for multisystem mitochondrial disease.
Peter Kurre, MD, Appointed Director of the Comprehensive Bone Marrow Failure Center
Published on in CHOP News
Dr. Kurre will lead a world-renowned, multidisciplinary team in developing new therapies for BMF syndromes and in basic research.
CHOP Opens Manufacturing Facility, Making Tools for Disease Cures
Published on in CHOP News
The grand opening of CHOP’s new Clinical Manufacturing Facility highlights its role in manufacturing tools for 21st century precision medicine, to bring innovative treatments to patients.